Efficacy and Safety of Regorafenib or TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies.
暂无分享,去创建一个
Y. Doki | M. Mori | T. Mizushima | D. Sakai | T. Kudo | T. Satoh | J. Nishimura | Hidekazu Takahashi | N. Haraguchi | T. Hata | T. Sugiura | Toshinori Sueda | Taro Hayashi | H. Takahashi